T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gen Digital
GEN
|
+$2.03B |
| 2 |
DuPont de Nemours
DD
|
+$1.83B |
| 3 |
Crown Castle
CCI
|
+$1.58B |
| 4 |
Microsoft
MSFT
|
+$1.48B |
| 5 |
TransUnion
TRU
|
+$781M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DD
Du Pont De Nemours E I
DD
|
+$1.72B |
| 2 |
Starbucks
SBUX
|
+$1.59B |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
+$1.3B |
| 4 |
Lowe's Companies
LOW
|
+$1.13B |
| 5 |
Philip Morris
PM
|
+$1.01B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.59% |
| 2 | Financials | 16.53% |
| 3 | Technology | 15% |
| 4 | Consumer Discretionary | 13.37% |
| 5 | Industrials | 9.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1026
SiriusXM
SIRI
$9.43B
| $31.3M | 0.01% |
567,319
-96,705
| -15% | -$5.35M |
|
1027
PBF Energy
PBF
$8.81B
| $31.3M | 0.01% |
1,132,060
+1,085,095
| +2,310% | +$25.1M |
|
|
CBM
1028
DELISTED
Cambrex Corporation
CBM
| $31.2M | 0.01% |
567,023
+36,622
| +7% | +$2.02M |
|
1029
Principal Financial Group
PFG
$24.6B
| $31.1M | 0.01% |
483,140
-12,986
| -3% | -$835K |
|
1030
CALL
Kraft Heinz
KHC
$30.1B
| $31M | 0.01% |
+400,000
| New | +$33.5M |
|
|
IPHI
1031
DELISTED
INPHI CORPORATION
IPHI
| $31M | 0.01% |
781,343
+40,291
| +5% | +$1.51M |
|
1032
Cibus
CBUS
$145M
| $31M | 0.01% |
+25,306
| New | +$21.5M |
|
1033
Republic Services
RSG
$65.9B
| $30.9M | 0.01% |
467,835
-31
| -0% | -$2.02K |
|
1034
Carlisle Companies
CSL
$14.9B
| $30.9M | 0.01% |
308,039
-958
| -0.3% | -$92.8K |
|
1035
Wynn Resorts
WYNN
$10.5B
| $30.9M | 0.01% |
207,159
-3,774
| -2% | -$515K |
|
|
CSW
1036
CSW Industrials
CSW
$5.59B
| $30.7M | 0.01% |
692,920
+106,242
| +18% | +$4.31M |
|
1037
Bio-Rad Laboratories Class A
BIO
$9.66B
| $30.6M | 0.01% |
137,751
+8,352
| +6% | +$1.88M |
|
1038
RenaissanceRe
RNR
$13.3B
| $30.6M | 0.01% |
226,164
+816
| +0.4% | +$115K |
|
|
SF
1039
Stifel
SF
$12.9B
| $30.5M | 0.01% |
1,282,851
-7,992
| -0.6% | -$173K |
|
|
DESP
1040
DELISTED
Despegar.com
DESP
| $30.4M | 0.01% |
+950,000
| New | +$30.3M |
|
1041
Manhattan Associates
MANH
$11.7B
| $30.3M | 0.01% |
728,321
+7,666
| +1% | +$336K |
|
1042
Oil-Dri
ODC
$1.27B
| $30.3M | 0.01% |
1,237,268
| – | – |
|
1043
Essent Group
ESNT
$6.23B
| $30.1M | 0.01% |
744,426
+17,534
| +2% | +$678K |
|
|
PRAH
1044
DELISTED
PRA Health Sciences, Inc.
PRAH
| $30M | 0.01% |
394,243
+40,911
| +12% | +$3.09M |
|
|
TEN
1045
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
| $29.8M | 0.01% |
491,921
+25,937
| +6% | +$1.46M |
|
1046
Editas Medicine
EDIT
$432M
| $29.7M | 0.01% |
1,235,341
-225,389
| -15% | -$4.29M |
|
1047
Commault Systems
CVLT
$6.26B
| $29.6M | 0.01% |
486,726
+56,544
| +13% | +$3.38M |
|
|
SYNH
1048
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $29.6M | 0.01% |
565,803
+36,678
| +7% | +$2.05M |
|
|
SIX
1049
DELISTED
Six Flags Entertainment Corp.
SIX
| $29.5M | 0.01% |
484,609
+17,505
| +4% | +$981K |
|
|
TSC
1050
DELISTED
TriState Capital Holdings, Inc.
TSC
| $29.5M | 0.01% |
1,287,561
-222,174
| -15% | -$5M |
|
Similar funds
T. Rowe Price Associates's Q3 2017 Portfolio in Review
As of Q3 2017, T. Rowe Price Associates held 2,642 positions worth $585B, up 5.3% from $556B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
T. Rowe Price Associates's Q3 2017 filing shows 88 new, 1,025 increased, 900 reduced and 73 closed positions. Its largest new stake was Brighthouse Financial: 4,532,679 shares worth $276M. The largest sale was Du Pont De Nemours E I, an estimated $1.72B.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 18% a quarter earlier, followed by Financials and Technology.
- T. Rowe Price Associates's largest Q3 2017 buy was Brighthouse Financial: 4,532,679 shares worth $276M.
- T. Rowe Price Associates added most to Gen Digital in Q3 2017, an estimated $2.03B increase.
- T. Rowe Price Associates's biggest Q3 2017 reduction was Starbucks, cutting an estimated $1.59B.
- T. Rowe Price Associates fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $1.72B.
- T. Rowe Price Associates's ten largest holdings make up 18% of its $585B portfolio in Q3 2017.
- T. Rowe Price Associates opened 88 new positions and closed 73 in Q3 2017.
- T. Rowe Price Associates's portfolio value rose 5.3% quarter-over-quarter to $585B.
Based on T. Rowe Price Associates's 13F filing for Q3 2017, filed 14 Nov 2017.